Latest in Will This New GLP 1 Drug be More Powerful Than Ozempic
Sort by
3,443 items
-
Will This New GLP-1 Drug be More Powerful Than Ozempic?
Investors seek answers on Novo Nordisk’s next-gen obesity drug, CagriSema.Inc. - 6h -
Regeneron’s earnings boosted by more than doubling of U.S. sales of blockbuster eye drug Eylea
Regeneron Pharmaceuticals Inc.’s stock rose 4.9% Tuesday to put it on track for its biggest one-day gain in almost two years, after the company posted better-than-expected fourth-quarter earnings, ...MarketWatch - 4h -
More than a million miss tax return deadline
Thousands of people left it to the last minute before the cut-off at the end of Friday.BBC News - 1d -
The Arc’teryx Toque Is More Than Just a Beanie
Worn by celebrities like Frank Ocean and Timothée Chalamet, the Arc’teryx toque isn’t only being used to keep heads warm.The New York Times - 3d -
Peace in Ukraine will require more than sanctions
President Trump has threatened to impose significant taxes, tariffs, and sanctions on Russia if a peace agreement is not reached promptly, but it remains to be seen if this approach will be ...The Hill - 5d -
Weekly Jobless Claims Drop More Than Expected
While job opportunities are becoming harder to find, the low layoff rate meant better results than the Labor Department’s forecast.Inc. - 5d -
White House hit with more than 7,000 'new media' press pass applications
The White House has received more than 7,000 applications for press passes after press secretary Karoline Leavitt announced Tuesday that the West Wing would open the briefing room up to members of ...The Hill - 6d -
The Los Angeles wildfires destroyed more than buildings
Leveling and rebuilding buildings will take several years. But restoring communities will take much longer.The Hill - 6d -
More than 140,000 homes still without power after Storm Éowyn
It could take up to 10 days for power to be restored to all of the affected properties, according to NIE.BBC News - Jan. 25 -
Ozempic maker’s stock surges. A trial of a new Novo Nordisk drug shows promise.
Novo Nordisk shares jumped on Friday as the Danish drugmaker said an experimental drug was able to reduce weight by as much as 22%.MarketWatch - Jan. 24 -
Ford recalls more than 270,000 Broncos and Mavericks due to loss of power problem
Ford Motor Co. is recalling more than 270,000 Broncos and Mavericks due to a power problem that can cause vehicles to stop unexpectedly or fail to startABC News - Jan. 24 -
A Wedding Ceremony Reflecting More Than Just Their Love
Sydney Hopfer and Jes Graham, who met three years ago, pushed up their wedding date and used the occasion to include “our political statement.”The New York Times - Jan. 22 -
UK borrows far more than expected in December
Government borrowing hits £17.8bn as chancellor Rachel Reeves faces pressure to turn around the economyFinancial Times - Jan. 22 -
Exciting news! The world is on track to have more than 1.5 degrees of warming and five trillionaires | First Dog on the Moon
What a remarkable coincidence . Sign up here to get an email whenever First Dog cartoons are published Get all your needs met at the First Dog shop if what you need is First Dog merchandise ...The Guardian - Jan. 22 -
The war on drugs needs a new tactic: shame
Liberal reformers have been too hesitant to spell out the negative consequences for othersFinancial Times - Jan. 21 -
Ozempic is in the next round of Medicare drug price negotiations. See the full list of 15 medications
The talks on drugs including Novo Nordisk's Wegovy, GSK's Trelegy Ellipta, and Pfizer's Xtandi will set Medicare prices that go into effect in 2027.CNBC - Jan. 17 -
Obesity drugs Ozempic and Wegovy included in US price-cut talks
Novo Nordisk shares hit as government adds blockbuster weight-loss treatments to new round of negotiationsFinancial Times - Jan. 17 -
Ozempic Among the Next Drugs Up for Medicare Price Negotiations
The list of drugs account for $41 billion in annual Medicare spending, the Biden administration said.The Wall Street Journal - Jan. 17 -
White House says popular weight-loss drug Ozempic subject to Medicare talks
Analysts at Argus Research say the stock is now trading at 22 times its estimated 2025 earnings.MarketWatch - Jan. 17 -
Medicare announces weight-loss drugs, including Ozempic, will be up for price negotiations
The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, which includes Ozempic.NBC News - Jan. 17 -
Ozempic, Wegovy on list for Medicare drug price negotiations
The hugely popular medications Ozempic and Wegovy, used for diabetes and weight loss, will be included in the next round of talks to negotiate lower Medicare drug prices.CBS News - Jan. 17 -
Biden administration picks 15 more drugs for Medicare negotiation
The Centers for Medicare and Medicaid Services (CMS) has selected 15 more drugs for Medicare price negotiation, announcing the selection two weeks ahead of schedule. Administration officials did ...The Hill - Jan. 17 -
1/16: CBS Evening News
Anxiety in Gaza, Israel over ceasefire; "Twin Peaks" creator and director David Lynch dies at 78CBS News - Jan. 17 -
How Ozempic Has Forever Changed How Much People Spend on Food, According to a New Cornell University Study
Ozempic doesn’t just reduce weight. Research shows GLP-1s also changes how much people spend on food, and the types of food they buy.Inc. - Jan. 16 -
1/15: CBS Evening News
Israel, Hamas reach ceasefire deal that will see pause in fighting, hostages released; NIL money in college athletics creating "have-not" sportsCBS News - Jan. 16 -
Amorim: Saints to teach me more than Arsenal
Ruben Amorim said he will learn more about his players when they face Southampton than during the performances against Liverpool and Arsenal.ESPN - Jan. 15 -
1/14: CBS Evening News
Pete Hegseth faces Senate grilling in confirmation hearing; Princess Catherine says cancer is in remissionCBS News - Jan. 15 -
More than 1 drink a day raises risk of dying, federal review concludes
The death risk goes up to 1 in 100 for those who drink alcohol nine times per week, the report found.CBS News - Jan. 14 -
The Mothers on Broadway Are Finally More Than Monsters
Onstage, the flip-side of filial devotion has often been contempt. But a wave of forceful and multidimensional mothers suggests that may be changing.The New York Times - Jan. 13 -
1/12: CBS Weekend News
Eaton Fire hits historically Black neighborhoods; A look at the efforts to save pets and animals from the California wildfiresCBS News - Jan. 13 -
1/11: CBS Weekend News
New evacuations ordered as stubborn Palisades Fire expands east in Los Angeles; California communities step up to help fire victimsCBS News - Jan. 12 -
1/10: CBS Evening News
Crews make slow progress battling Southern California wildfires; How a beloved geology professor's bond with a former student transcends illnessCBS News - Jan. 11 -
The TikTok Ban Is More Likely Than Ever
While Supreme Court justices pressed both sides in Friday’s oral arguments, experts say it’s hard to see how TikTok gets enough votes to survive.Wired - Jan. 10 -
1/9: CBS Evening News
Los Angeles officials face questions, criticism as out-of-control wildfires continue to rage; How to help Southern California wildfire victimsCBS News - Jan. 10 -
Weight-loss drugs like Ozempic may be up for Medicare price negotiations — will Trump support it?
Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face an uncertain future in the incoming Trump administration.NBC News - Jan. 9 -
1/8: CBS Evening News
Firestorm brings death, destruction to Los Angeles County; Los Angeles fire official on the challenges crews are facingCBS News - Jan. 9 -
1/7: CBS Evening News
Strong winds fuel rapidly expanding wildfires in Southern California; Peter Yarrow, of Peter, Paul, and Mary, dies at age 86CBS News - Jan. 8 -
1/6: CBS Evening News
Deadly winter storm sweeps across the country; Demi Moore says Golden Globe win is reminder "I do belong"CBS News - Jan. 7 -
Less than 1 in 1,000 adolescents received gender-affirming medications: Study
Less than 1 in 1,000 adolescents with commercial insurance received gender-affirming medication over a five-year period, according to a study released Monday. The researchers in the study surveyed ...The Hill - Jan. 6
